Guoling Xi
AstraZeneca (Australia)(AU)AstraZeneca (Poland)(PL)
Publications by Year
Research Areas
Viral Infectious Diseases and Gene Expression in Insects, Virus-based gene therapy research, Viral gastroenteritis research and epidemiology, Protein purification and stability, Immune Response and Inflammation
Most-Cited Works
- → Developing an Anion Exchange Chromatography Assay for Determining Empty and Full Capsid Contents in AAV6.2(2019)105 cited
- → Congenital Exposure toPlasmodium falciparumAntigens: Prevalence and Antigenic Specificity of In Utero-Produced Antimalarial Immunoglobulin M Antibodies(2003)50 cited
- → Novel signal peptides improve the secretion of recombinant Staphylococcus aureus Alpha toxinH35L in Escherichia coli(2017)29 cited
- → Development and scale‐up of a commercial fed batch refolding process for an anti‐CD22 two chain immunotoxin(2014)24 cited
- → Safety risk management for low molecular weight process‐related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential(2020)18 cited
- → Identification of compendial nonionic detergents for the replacement of Triton X‐100 in bioprocessing(2022)17 cited
- → Purification of a recombinant oncolytic virus from clarified cell culture media by anion exchange monolith chromatography(2023)12 cited
- → Refolding and purification of cGMP-grade recombinant human neurturin from Escherichia coli inclusion bodies(2019)7 cited
- → Size-exclusion chromatography as a multi-attribute method for process and product characterization of adeno-associated virus(2024)7 cited
- → Front Cover: Purification of a recombinant oncolytic virus from clarified cell culture media by anion exchange monolith chromatography(2023)